Research

Displaying 241 - 250 of 277 Articles
MS Ireland
30 Aug 2012

Impact of Sleep Disorder Treatments on Fatigue

Fatigue is one of the symptoms people with MS commonly experience, and for some, it’s the symptom that affects them the most. While the experience of fatigue varies from person to person, the effects can be felt both mentally and physically, leading fatigue to impact on daily life. 

MS Ireland
17 Aug 2012

Is it MS? Survey Results

The Multiple Sclerosis International Federation (MSIF) has published the results of its ‘Is it MS?’ survey. The survey was carried out in early 2012 with over 4000 people taking part, sharing their experience of being diagnosed with MS.

MS Ireland
31 Jul 2012

FDA Consider Alemtuzumab

For a number of years we have mentioned the possibility of a new drug called Alemtuzumab being a potential new treatment for people with MS. On 12 June 2012 the makers, Genzyme, announced that the company has made an official application to the Food and Drugs Administration (FDA) in the US and the European Medicines Agency (EMA).

MS Ireland
10 Jul 2012

Gilenya Now Prescribed

Fingolimod, under the trade name Gilenya, the first oral drug therapy for the treatment of MS, is now available under the direction of a neurologist. Gilenya is licensed as a second line therapy, making it suitable for people that have failed on conventional first line therapies or those individuals with highly active MS.

Top